Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis

BACKGROUND: Patients with metabolic syndrome (MetS) have a 2.6-fold greater risk of incident chronic kidney disease (CKD). The primary goal of this study was to assess the prevalence of MetS in patients with end-stage renal disease (ESRD) who are on hemodialysis (HD) and the impact of MetS presence...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med Res
Auteurs principaux: Alswat, Khaled A., Althobaiti, Awwadh, Alsaadi, Khulod, Alkhaldi, Amaal Saeed, Alharthi, Maryam Mutlaq, Abuharba, Walaa Abduraheem, Alzaidi, Ahmed A.
Format: Artigo
Langue:Inglês
Publié: Elmer Press 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505305/
https://ncbi.nlm.nih.gov/pubmed/28725317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3064w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires